After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Insmed Inc is $39.72B. A total of 3.07 million shares were traded on the day, compared to an average of 2.46M shares.
In the most recent transaction, Michael A Smith bought 27,130 shares of INSM for 183.75 per share on Nov 03 ’25. In a previous transaction on Sep 12 ’25, Schaeffer Orlov S Nicole sold 76,520 shares at 145.45 per share. INSM shares that Chief People Strategy Officer owns now total 36,461.
Among the insiders who sold shares, SHAROKY MELVIN MD disposed of 10,000 shares on Sep 12 ’25 at a per-share price of $145.39. This resulted in the Director holding 262,675 shares of INSM after the transaction. In another insider transaction, Schaeffer Orlov S Nicole bought 76,520 shares at $145.42 per share on Sep 12 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, INSM has a high of $197.08 and a low of $60.40.
As of this writing, INSM has an earnings estimate of -$1.37 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$1.09 per share and a lower estimate of -$1.86. The company reported an EPS of -$1.32 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. INSM’s latest balance sheet shows that the firm has $716.78M in Cash & Short Term Investments as of fiscal 2021. There were $612.27M in debt and $135.17M in liabilities at the time. Its Book Value Per Share was $4.45, while its Total Shareholder’s Equity was $410.47M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INSM is Buy with a score of 4.75.
